|
|
|
|
pmid:
|
|
|
|
|
pmid:3360596
|
|
|
|
|
pmid:9870780
|
Pastores SM et al. |
Posttraumatic multiple-organ dysfunction syndrome: role of mediators in systemic inflammation and subsequent organ failure. |
1996 |
Acad Emerg Med |
pmid:8727633
|
Goldring WP and Pattenden G |
The phomactins. A novel group of terpenoid platelet activating factor antagonists related biogenetically to the taxanes. |
2006 |
Acc. Chem. Res. |
pmid:16700534
|
Yamada T et al. |
Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs. |
1998 |
Acta Anaesthesiol Scand |
pmid:9542566
|
Nathan N et al. |
Variations in blood platelet-activating-factor levels after protamine reversal of heparin in humans. |
1992 |
Acta Anaesthesiol Scand |
pmid:1574976
|
Sipka S et al. |
Atropine is an inhibitor of the chemiluminescence induced by platelet-activating factor in human neutrophils. |
1987 |
Acta Biochim. Biophys. Hung. |
pmid:3132002
|
Ren J et al. |
Protective effect of dexmedetomidine against myocardial ischemia-reperfusion injury in rabbits. |
2018 |
Acta Cir Bras |
pmid:29412230
|
Peterson JR et al. |
Platelet activating factor antagonist design. 3. X-ray crystal structure and intermolecular crystal lattice interactions of methyl trans-4-acetoxymethyl-4,5-dihydro-2,5-bis(3,4-methylenedioxyphenyl)- 3-furancarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2604943
|
Peterson JR et al. |
Platelet activating factor antagonist design: structure of methyl trans-5-(3,4-dimethoxyphenyl)-2,3,4,5-tetrahydro-2-oxo-4- furancarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2610971
|
Peterson JR et al. |
Platelet activating factor antagonist design. 2. X-ray structure of dimethyl 2,3,4,5-tetrahydro-5 beta-(3,4-methylenedioxyphenyl)-2-oxo-3 beta-(3,4,5-trimethoxybenzoyl)-3 alpha,4 alpha-furandicarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2610989
|
Stensland JB et al. |
Platelet activating factor antagonists. Structure of N,N'-bis(3,4,5-trimethoxybenzoyl)-2-piperazinylmethyl 2,2-dimethylpropanoate. |
1991 |
Acta Crystallogr C |
pmid:1930821
|
Juhlin L and Pihl-Lundin I |
Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects. |
1992 |
Acta Derm. Venereol. |
pmid:1357858
|
Juhlin L and Rihoux JP |
Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria. |
1990 |
Acta Derm. Venereol. |
pmid:1969202
|
Fjellner B and Hägermark O |
Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. |
1985 |
Acta Derm. Venereol. |
pmid:2416164
|
Abramovici Y et al. |
Control of the proliferation and differentiation of GEJ under platelet aggregating factor treatment. |
1987 |
Acta Endocrinol Suppl (Copenh) |
pmid:3475908
|
Plachot M |
Markers for establishing the adequacy of embryonal development in assisted conception. |
1993 Sep-Oct |
Acta Eur. Fertil. |
pmid:7985464
|
Aderka D et al. |
Morphological platelet anomalies in thrombotic thrombocytopenic purpura. |
1982 |
Acta Haematol. |
pmid:6801893
|
Bussolino F et al. |
Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy. |
1986 |
Acta Haematol. |
pmid:3019063
|
Akisü M et al. |
The effect of L-carnitine on platelet activating factor concentration in the immature rat model of hypoxic-ischemic brain injury. |
1998 |
Acta Med. Okayama |
pmid:9781268
|
Hashimoto K et al. |
Comparison of the effects of intra-third ventricular administration of interleukin-1 or platelet activating factor on ACTH secretion and the sympathetic-adrenomedullary system in conscious rats. |
1993 |
Acta Med. Okayama |
pmid:8384777
|
Vargaftig BB et al. |
One, two, three or more pathways for platelet aggregation. |
1980 |
Acta Med. Scand. Suppl. |
pmid:6779505
|
Hirasima Y et al. |
Platelet-activating factor (PAF) and the development of chronic subdural haematoma. |
1994 |
Acta Neurochir (Wien) |
pmid:7998491
|
Hirashima Y et al. |
Platelet-activating factor (PAF) and the formation of chronic subdural haematoma. Measurement of plasma PAF levels and anti-PAF immunoglobulin titers. |
1995 |
Acta Neurochir (Wien) |
pmid:8748861
|
Hirashima Y et al. |
Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage. |
1994 |
Acta Neurochir (Wien) |
pmid:7847132
|
Hallenbeck JM |
Blood-damaged tissue interaction in experimental brain ischemia. |
1994 |
Acta Neurochir Suppl (Wien) |
pmid:7976554
|
Tokutomi T et al. |
Effect of platelet-activating factor antagonist on brain injury in rats. |
1994 |
Acta Neurochir Suppl (Wien) |
pmid:7976632
|
Maeda T et al. |
Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. |
1997 |
Acta Neurochir. Suppl. |
pmid:9416292
|
Khan SN et al. |
Response to platelet-activating factor of platelets from patients with multiple sclerosis. |
1985 |
Acta Neurol. Scand. |
pmid:3993327
|
Satoh K et al. |
Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. |
1992 |
Acta Neurol. Scand. |
pmid:1574985
|
Doly M et al. |
Protective effect of a specific PAF antagonist on vincristine-induced experimental retinopathy. |
1995 |
Acta Ophthalmol Scand |
pmid:7656145
|
Pettorossi VE and Grassi S |
Different contributions of platelet-activating factor and nitric oxide in long-term potentiation of the rat medial vestibular nuclei. |
2001 |
Acta Otolaryngol Suppl |
pmid:11677732
|
Nakano T et al. |
Roxythromycin reinforces epithelial defence function in rabbit trachea. |
1998 |
Acta Otolaryngol Suppl |
pmid:9879427
|
Minami T et al. |
Regional blood flow volume in the eustachian tube. |
1993 |
Acta Otolaryngol Suppl |
pmid:8452027
|
Lin J et al. |
Effects of platelet-activating factor (PAF) receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelium. |
1996 |
Acta Otolaryngol. |
pmid:8820353
|
Terada N et al. |
The effect of anti-VLA-4 monoclonal antibody on eosinophil accumulation and leukotriene production in nasal mucosa. |
1996 |
Acta Otolaryngol. |
pmid:8973726
|
Ganbo T and Hisamatsu K |
Mucosal dysfunction and damage induced by platelet activating factor (PAF). |
1990 Nov-Dec |
Acta Otolaryngol. |
pmid:2284918
|
Minami T et al. |
Effects of various inflammatory mediators on eustachian tube patency. |
1992 |
Acta Otolaryngol. |
pmid:1442015
|
Dolata J et al. |
The influence of leukotrienes and platelet activating factor on mucociliary activity in the rabbit maxillary sinus. |
1990 Jan-Feb |
Acta Otolaryngol. |
pmid:2309553
|
Furukawa M et al. |
Presence of platelet-activating factor in nasal polyps and eosinophils. |
2002 |
Acta Otolaryngol. |
pmid:12542208
|
Lin J et al. |
Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells. |
1997 |
Acta Otolaryngol. |
pmid:9199527
|
Bellioni P et al. |
[Histomorphological changes in nasal polyps in patients with glucose metabolism disorders]. |
1988 Nov-Dec |
Acta Otorhinolaryngol Ital |
pmid:3247845
|
Akisü M et al. |
Plasma platelet-activating factor levels in newborn infants with and without perinatal asphyxia: is it an additional marker of perinatal asphyxia? |
1998 |
Acta Paediatr Jpn |
pmid:9821700
|
Hüseyinov A et al. |
Plasma and urinary platelet activating factor concentrations and leukotriene releasing activity of leukocytes in steroid sensitive nephrotic syndrome of childhood. |
1998 |
Acta Paediatr Jpn |
pmid:9583202
|
Nagakura T et al. |
Chemical mediators in hypersensitivity reactions. |
1990 |
Acta Paediatr Jpn |
pmid:1974103
|
Ewer AK |
Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. |
2002 |
Acta Paediatr Suppl |
pmid:12200892
|
Hsueh W et al. |
Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis. |
1994 |
Acta Paediatr Suppl |
pmid:8086673
|
Dahlbäck M et al. |
Bronchial anaphylaxis in actively sensitized Sprague Dawley rats: studies on mediators involved. |
1984 |
Acta Pharmacol Toxicol (Copenh) |
pmid:6431753
|
Saeed SA and Rasheed H |
Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation. |
2003 |
Acta Pharmacol. Sin. |
pmid:12511226
|
Penna C et al. |
Post-ischaemic activation of kinases in the pre-conditioning-like cardioprotective effect of the platelet-activating factor. |
2009 |
Acta Physiol (Oxf) |
pmid:19432589
|
Lang F et al. |
Osmotic shock-induced suicidal death of erythrocytes. |
2006 May-Jun |
Acta Physiol (Oxf) |
pmid:16734755
|
Kecskemeti V |
Electrophysiological effects of platelet-activating factor (PAF) in guinea-pig cardiac preparations. |
1990 |
Acta Physiol Hung |
pmid:2371852
|
Balogh I et al. |
Cytochemical effects of biologically active substances on the heart muscle. |
1990 |
Acta Physiol Hung |
pmid:2371866
|
Alving K et al. |
The possible role of prostaglandin D2 in the long-lasting airways vasodilatation induced by allergen in the sensitized pig. |
1991 |
Acta Physiol. Scand. |
pmid:1957709
|
Arner M and Högestätt ED |
Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries. |
1991 |
Acta Physiol. Scand. |
pmid:1715111
|
Björk J et al. |
Paf-acether (platelet-activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds. |
1983 |
Acta Physiol. Scand. |
pmid:6659994
|
Karlström G et al. |
Renal and circulatory effects of medullipin I, as studied in the in-vivo cross-circulated isolated kidney and intact Wistar-Kyoto (WKY) rat. |
1989 |
Acta Physiol. Scand. |
pmid:2603751
|
Iversen VV et al. |
Platelet activating factor (PAF) increases plasma protein extravasation and induces lowering of interstitial fluid pressure (P) in rat skin. |
2005 |
Acta Physiol. Scand. |
pmid:16128692
|
Greiff L et al. |
Effects of topical platelet activating factor on the guinea-pig tracheobronchial mucosa in vivo. |
1997 |
Acta Physiol. Scand. |
pmid:9338520
|
Zia-ul-Haq M et al. |
Platelet aggregation and anti-inflammatory effects of garden pea, Desi chickpea and Kabuli chickpea. |
2012 Jul-Aug |
Acta Pol Pharm |
pmid:22876614
|
Rubio de Krömer MT et al. |
Differences in eosinophil and neutrophil chemotactic responses in sowda and generalized form of onchocerciasis. |
1995 |
Acta Trop. |
pmid:8546035
|
Konstantinov SM et al. |
Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies. |
1997 |
Acta Trop. |
pmid:9107362
|
Dutra PM et al. |
Stimulation of Leishmania tropica protein kinase CK2 activities by platelet-activating factor (PAF). |
2009 |
Acta Trop. |
pmid:19433049
|
Bazan NG and Allan G |
Platelet-activating factor is both a modulator of synaptic function and a mediator of cerebral injury and inflammation. |
1996 |
Adv Neurol |
pmid:8790822
|
Söling HD et al. |
Regulation of protein kinases in exocrine secretory cells during agonist-induced exocytosis. |
1985 |
Adv. Enzyme Regul. |
pmid:4072796
|
|
Proceedings of an International Symposium on Mechanisms of Platelet Activation and Control. London, United Kingdom, April 13-14, 1992. |
1993 |
Adv. Exp. Med. Biol. |
pmid:7911646
|
Kornecki E et al. |
Interactions of the alkyl-ether-phospholipid, platelet activating factor (PAF) with platelets, neural cells, and the psychotropic drugs triazolobenzodiazepines. |
1987 |
Adv. Exp. Med. Biol. |
pmid:2893525
|
Hanahan DJ |
The continuing biochemical challenge of PAF and closely related lipid mediators. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131117
|
Snyder F et al. |
Biosynthesis of platelet-activating factor and enzyme inhibitors. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131118
|
Satoh K et al. |
Production of platelet-activating factor by brain microvascular endothelial cells. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131120
|
Francescangeli E et al. |
PAF-synthesizing enzymes in neural cells during differentiation and in gerbil brain during ischemia. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131121
|
Yamada M et al. |
Platelet-activating factor production in the stimulated macrophages is enhanced by the cyclooxygenase inhibitors. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131122
|
van den Bosch H et al. |
The role of peroxisomes in ether lipid synthesis. Back to the roots of PAF. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131123
|
Dohi T et al. |
Platelet-activating factor synthesis and its role in salivary glands. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131124
|
Nakayama R et al. |
Physiological action of PAF in yeast Saccharomyces cerevisiae. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131125
|
Demopoulos CA and Antonopoulou S |
A discovery trip to compounds with PAF-like activity. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131127
|
Rementzis J et al. |
Biologically active lipids from S. scombrus. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131128
|
Narahara H et al. |
Role of platelet-activating factor in parturition. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131160
|
Ahmed A and Dearn S |
The role of platelet-activating factor and its receptor in endometrial receptivity. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131161
|
Korth RM |
Non-specific PAF binding to embryonal F9 cells and prostacyclin synthesis in human umbilical vein endothelial cells. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131162
|
Zimmerman GA et al. |
Platelet-activating factor (PAF): signalling and adhesion in cell-cell interactions. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131163
|
Yang HC et al. |
Characterization of plasmalogen-selective phospholipase A2 from bovine brain. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131165
|
Ferby I et al. |
PAF-induced MAPK activation is inhibited by wortmannin in neutrophils and macrophages. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131167
|
Thierse HJ et al. |
Evidence for activation of cyclooxygenase-1/-2 by endogenous nitric oxide in adjuvant arthritic Lewis rats. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131171
|
Curtis LD |
Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131174
|
McKay C et al. |
The use of lexipafant in the treatment of acute pancreatitis. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131175
|
Tamura G et al. |
Effect of a potent platelet-activating factor antagonist, WEB-2086, on asthma. A multicenter, double-blind placebo-controlled study in Japan. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131176
|
Albert DH et al. |
Ex vivo inhibition of PAF-induced beta-thromboglobulin release in man by ABT-299, a potent PAF antagonist. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131177
|
Camussi G et al. |
The release of platelet-activating factor during phagocytosis by polymorphonuclear neutrophils and monocytes. |
1982 |
Adv. Exp. Med. Biol. |
pmid:7090917
|
Maes L et al. |
In vivo arterial platelet-vessel wall interaction and thrombosis: induction, on-line registration and ultrastructural control. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3832867
|
Tuffin DP et al. |
Specific binding of [3H]-1-O-octadecyl Paf-acether to washed human platelets. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3834789
|
MacIntyre DE et al. |
Agonist-induced inositol phospholipid metabolism and Ca++ flux in human platelet activation. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3010662
|
Hallam TJ et al. |
Control and interrelation of aggregation and secretion; the roles of Ca2+, diacylglycerol and thromboxane with particular reference to ADP stimulation. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3010663
|
Gerrard JM et al. |
Platelet protein phosphorylation. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3010667
|
Haslam RJ et al. |
Receptor-effector coupling in platelets: roles of guanine nucleotides. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3010668
|
Braquet P and Bourgain RH |
Anti-anaphylactic properties of BN 52021: a potent platelet activating factor antagonist. |
1987 |
Adv. Exp. Med. Biol. |
pmid:3314403
|
Winkler JD et al. |
Inhibitors of arachidonate metabolism and effects on PAF production. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131119
|
Elizarova EP |
Effects of taurine on calcium in platelets and their aggregation. |
1996 |
Adv. Exp. Med. Biol. |
pmid:8915398
|
Vadas P and Pruzanski W |
Phospholipase A2 activation is the pivotal step in the effector pathway of inflammation. |
1990 |
Adv. Exp. Med. Biol. |
pmid:2239447
|